TB and COVID-19: paying attention to diabetes mellitus

被引：5

作者：

Harries, Anthony D. ^{[1
,2
]}

Kumara, Ajay M. V. ^{[1
,3
,4
]}

Satyanarayana, Srinath ^{[1
,3
]}

Lin, Yan ^{[1
]}

Dlodlo, Riitta A. ^{[1
]}

Khogali, Mohammed ^{[5
]}

Zachariah, Rony ^{[5
]}

Kapur, Anil ^{[6
]}

机构：

[1] Int Union TB & Lung Dis, 68 Blvd St Michel, F-75006 Paris, France

[2] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Clin Res, Keppel St, London WC1E 7HT, England

[3] Int Union TB & Lung Dis, Qutub Inst Area C6, South East Asia Off, New Delhi 110016, India

[4] Yenepoya Deemed Be Univ, Yenepoya Med Coll, Univ Rd, Mangalore 575018, India

[5] World Hlth Org, Special Programme Res & Training Trop Dis TDR, Ave Appia 20, CH-1211 Geneva, Switzerland

[6] World Diabet Fdn, Krogshoejvej 30A,Bldg 8Y2, DK-2880 Bagsvaerd, Denmark

来源：

TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE | 2021年 / 115卷 / 06期

关键词：

COVID-19; diabetes mellitus; SARS-CoV-2; TB; TUBERCULOSIS;

D O I：

10.1093/trstmh/trab035

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

In 2019, global diabetes prevalence was 463 million. Diabetes increases the risk of TB and adverse treatment outcomes including death and relapse. Diabetes also increases the risk of severe disease, multi-organ failure, coagulopathy and death in COVID-19. TB and COVID-19 share many features, suggesting opportunities to integrate prevention, diagnosis and care. Three areas for further work are highlighted: better infection control in diabetes clinics, easier and quicker diagnosis using similar technology platforms and optimal blood glucose control. The funding and resources for COVID-19 should be harnessed to improve TB and diabetes care and achieve their respective sustainable development goal targets.

引用

页码：600 / 602

页数：3

共 50 条

[1] Paying Attention to Circadian Rhythms in the Treatment of COVID-19
Bakhtazad, Atefeh
Jafari, Reza
Khaksari, Mehdi
Khastar, Hossein
Salehi, Majid
Jafarisani, Moslem
Garmabi, Behzad
[J]. BASIC AND CLINICAL NEUROSCIENCE, 2020, 11 (02) : 233 - 245
[2] Covid-19 and Diabetes Mellitus
Attri, Bhawna
Gupta, Yashdeep
Tandon, Nikhil
[J]. NATIONAL MEDICAL JOURNAL OF INDIA, 2021, 34 (03): : 129 - 131
[3] Comparison of Serum Adropin Levels in Patients with Diabetes Mellitus, COVID-19, and COVID-19 with Diabetes Mellitus
Aydin, Pelin
Uzuncakmak, Sevgi Karabulut
Tor, Ibrahim Hakki
Bilen, Arzu
Ozden, Ayse
[J]. EURASIAN JOURNAL OF MEDICINE, 2022, 54 (02): : 197 - 201
[4] Diabetes mellitus in Zeiten von COVID-19Diabetes mellitus in the time of COVID-19
Klaus G. Parhofer
[J]. MMW - Fortschritte der Medizin, 2021, 163 (1) : 45 - 47
[5] COVID-19 and Diabetes Mellitus: A Complex Interplay
Koneru, Gopala
Sayed, Hager H.
Abd-elhamed, Nayera A.
Elsedfy, Nouran
Mohamed, Amira H.
Abdellatif, Hania A.
Mohamed, Fatmaalzharaa F.
Bahnasawy, Esraa H.
Mousa, Nayera K.
Eisa, Aml
Elshenawy, Esraa A.
Basheer, Yassmin Z.
Sayed, Esraa H.
Mohamed, Farah F.
Ali, Walaa R.
Soliman, Hadir A.
Eltabary, Ashrakt A.
Sayed, Noorhan M.
Nasr, Nourhan H.
Khairallah, Nour S.
Hetta, Helal F.
[J]. JOURNAL OF PURE AND APPLIED MICROBIOLOGY, 2021, 15 (02): : 512 - 523
[6] Is diabetes mellitus a wrongdoer to COVID-19 severity?
Sarkar, Sanjib
Das, Dibyendu
Wann, Sawlang Borsingh
Kalita, Jatin
Manna, Prasenjit
[J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 178
[7] Diabetes Mellitus, Energy Metabolism, and COVID-19
Conte, Caterina
Cipponeri, Elisa
Roden, Michael
[J]. ENDOCRINE REVIEWS, 2024, 45 (02) : 281 - 308
[8] Diabetes mellitus and COVID-19: The ominous duo
Bhadada, Sanjay Kumar
Pal, Rimesh
[J]. INTERNATIONAL JOURNAL OF NONCOMMUNICABLE DISEASES, 2020, 5 (03) : 99 - 101
[9] COVID-19 pandemic, coronaviruses, and diabetes mellitus
Muniyappa, Ranganath
Gubbi, Sriram
[J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2020, 318 (05): : E736 - E741
[10] COVID-19 and Diabetes Mellitus: Prevalence and Precautions
Iqbal, Mohammad Zahidul
Zohra, Benazeer
[J]. ANNALS OF KING EDWARD MEDICAL UNIVERSITY LAHORE PAKISTAN, 2020, 26 : 218 - 225

← 1 2 3 4 5 →